Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 6,862

Document Document Title
WO/2010/125466A1
Methods for producing amrubicin and structural analogs thereof. The present invention encompasses synthetic pathways for the production of amrubicin (Formula I) and structural analogs thereof. The synthetic pathways of the present invent...  
WO/2010/123016A1
Disclosed is a compound having a GPR40 agonistic activity and useful for use in a pharmaceutical composition or useful as an insulin secretion promoter or a prophylactic or therapeutic agent for diabetes. Extensive studies have been made...  
WO/2010/122968A1
Disclosed is a compound useful as an anti-obesity agent. Studies have been made on compounds which have a DGAT1 inhibitory activity and are therefore promising active ingredients for pharmaceutical compositions for treating obesity, type...  
WO/2010/119161A2
The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form...  
WO/2010/113813A1
Disclosed are: a base-generating agent which has a high sensitivity and a wide application range; and a photosensitive resin composition which has a wide range of application choices owing to the structure of a polymer precursor the reac...  
WO2010110409A1
A pyrone derivative and a pyridone derivative which are intermediates for a novel anti-influenza drug; a process for producing these derivatives; and methods of using these derivatives.  
WO/2010/102848A1
Compounds of Formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2010/102003A2
In one aspect, the invention relates to compounds which are useful as as inhibitors of glycine type 1 transporter (GIyT1) activity; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and met...  
WO/2010/098583A2
The present invention relates to a novel method for preparing statin compounds or salts thereof, which are useful in treating and preventing hyperlipidemia-related diseases, and to intermediate compounds used in same. The method of the p...  
WO/2010/097374A1
The invention relates to the compounds of the general formula (I) wherein n, R1, R2, R3, R4, R5, R6, R7 and R8 are defined as described in the description, to enantiomers thereof, to diastereomers thereof, to mixtures and salts thereof, ...  
WO/2010/095506A1
A liquid-crystalline compound which not only has a large negative value of permittivity anisotropy (Δε) but also has at least one property selected from stability to heat, light, etc., a high clear point, adequate refractive-index anis...  
WO/2010/095768A1
The present invention provides 4-isopropylphenyl glucitol compounds which have no tendency to accumulate in the body and which inhibit SGLT1 activity to suppress postprandial hyperglycemia (or impaired glucose tolerance) through suppress...  
WO/2010/093706A2
Provided herein is a method for chemically programmed vaccination. Methods include inducing a covalent-binding polyclonal antibody response in a subject and programming the polyclonal response with a targeting compound.  
WO/2010/092154A1
The invention relates to substituted indanes and derivatives thereof, to physiologically acceptable salts and physiologically functional derivatives thereof, to the production thereof, to drugs containing at least one substituted indane ...  
WO/2010/092153A1
The invention relates to substituted tetrahydronapthalenes, to derivatives thereof, to physiologically acceptable salts thereof, to physiologically functional derivatives, to the production thereof, to drugs containing at least one subst...  
WO/2010/090305A1
Disclosed is an excellent agent for treatment or prevention of dementia, schizophrenia and the like, which has a serotonin 5-HT5A receptor modulating activity. An acylguanidine derivative represented by formula (I), wherein guanidine is ...  
WO/2010/089211A1
Compounds of Formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2010/090304A1
Disclosed is an excellent agent for treatment or prevention of dementia, schizophrenia and the like, which has a serotonin 5-HT5A receptor modulating activity. An acylguanidine derivative represented by formula (I), wherein guanidine is ...  
WO/2010/089210A1
Compounds of Formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2010/083732A1
N-acetylneuraminic acid compounds of formula I as follows, pharmaceutical composition, preparation method and uses thereof. The compounds can inhibit surface neuraminidase of influenza virus, thus can be used for resisting influenza viru...  
WO/2010/081894A1
Compounds of formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2010/082661A1
Disclosed is a composition for ameliorating postcibal hyperglycemia which comprises at least one member selected from the group consisting of 1,5-D-anhydroglucitol, 1,5-D-anhydrofructose and derivatives of the same. Also disclosed is a c...  
WO/2010/081755A1
Compounds of formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.  
WO/2010/074327A1
There is provided a halogen-containing organosulfur compound having a controlling effect on arthropod pests represented by the formula (I): wherein m represents 0, 1 or 2; n represents 0, 1 or 2; A represents an optionally substituted 3-...  
WO/2010/075280A2
Compounds including those of the Formula I where X, R1, R2 and subscript t are as defined herein, useful as γ-secretase inhibitors, are provided, as are compositions comprising the compounds, as well as methods for use of the compounds ...  
WO/2010/070910A1
Disclosed is a 1-heterodiene derivative represented by the formula (2); or, a salt thereof. In formula (2), W represents a hydrogen atom or the like; A, an oxygen atom or the like; R1, a C1-6 alkyl group or the like that is unsubstituted...  
WO/2010/069979A1
The compounds of formula (1) wherein A, B, R1, R2 and R3 have the meanings as given in the description, the stereoisomers, as well as the salts of the stereoisomers thereof are effective CCR3 modulators.  
WO/2010/069593A1
The invention relates to an improved process comprising amphiphilic compounds for the crystallization of an intermediate used in the process for the preparation of statins and statin intermediates.  
WO/2010/066909A2
The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F; or a pharmaceutically acceptable salt thereof. The present invention further relates to p...  
WO/2010/067036A1
The present invention relates to novel compounds of formula (I) where: X is an –OH or =O grouping; n is an integer between 0 and 5; R’ is H or a C1-C4 alkyl radical, when n ≥ 2, two adjacent –OR’ groupings can together form the...  
WO/2010/067176A1
Novel processes and intermediates are provided according to the general reaction scheme: Formula I, II, III, IV (I), (II), (III), (IV) utilizing a ruthenium catalyst in an oxidative cleavage of the triene 4 whereby an aldehyde may be pro...  
WO/2010/063742A1
The invention relates to a method for producing delta valerolactone (VLO) in the gas phase using catalytic dehydrogenation on at least two different catalysts.  
WO/2010/063948A2
The present invention relates to novel compound of formula I, where R is a hydrogen atom or a C1–C22 saturated or C2–C22 unsaturated linear alkyl radical, or a C3–C22 saturated or unsaturated branched alkyl radical, said alkyl radi...  
WO/2010/063802A1
The present invention relates to compounds of formula (I) wherein R1, R2, Ar, p, R4 and R5 are as defined herein, which are useful for creating diseases which respond to CXCR2 receptor mediators. Pharmaceutical compositions that contain ...  
WO/2010/063953A2
The present invention relates to novel compounds of formula (I) where R is: a C2–C18 alkyl radical, or a –CHR1 –COOR2 radical, where: R1 is H or a C1–C6 alkyl radical, and R2 is a C1–C6 linear alkyl radical, a C3–C6 cyclic al...  
WO/2010/063773A1
The present invention relates to novel 4- (heterocycloalkyl) benzene- 1, 3-diol compounds corresponding to general formula (I) below: to the compositions containing same, to the process for the preparation thereof and to the use thereof ...  
WO/2010/061182A2
The present invention provides a process for preparing methyl 5-acetamido-4-amino-6- (1,2,3-triacetoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylate (V), which process comprises reducing methyl 5-acetamido-4-azido-6-(1,2,3-triacetoxypropyl)-...  
WO/2010/061282A1
The present invention relates to compounds having general formula (I), i.e. poly- alkyl -bis -maltolic molecules and in particular to derivates of [ (3 -hydroxy- 4 -pyron- 2 -yl) methyl] -amine and pharmaceutically acceptable salts there...  
WO/2010/051935A2
The present invention relates to substituted amido phenoxybenzamide compounds of general formula (I) in which A, R1, R2, R3, R4, R5, R6, R7, R8, R9 and n are as defined in the claims, to pharmaceutical compositions and combinations conta...  
WO/2010/051028A1
Compounds of the Formula (I), wherein R2 is a branched or unbranched, saturated or ethylenically mono or di unsaturated aliphatic radical, Z is -CH2OH, -CH2OAc or -CHO, m is a whole positive integer of one or more, and Ac is an acetyl gr...  
WO/2010/046194A1
Cyclohexanedione compounds, which are suitable for use as herbicides.  
WO/2010/043748A1
A procedure is described for the obtainment of derivatives of monacolin J (I), wherein R1 is COR2, wherein R2 is selected from C1-C15 alkyl, C3-C15 cycloalkyl, C2-C15 alkenyl, C2-C15 alkynyl, aryl and heterocyclyl, comprising the product...  
WO/2010/040843A2
The invention relates to compounds of formula (I), in which R1, R2, R3, R4, X and Y are defined as cited in the description. The compounds have an immune-modulating action and inhibit or regulate the release of IL-1β and/or TNF-α. They...  
WO/2010/038167A1
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I) : as defined in the specification. The invention is also directed to compositions co...  
WO/2010/032988A2
The present invention relates to a kojic acid metal complex derivative bonded with an amino acid. More specifically, the invention relates to a kojic acid metal complex derivative into which an amino acid is introduced, and a preparation...  
WO/2010/031813A1
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of, interalia, metabolic disorders.  
WO/2010/031820A1
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of metabolic disorders.  
WO/2010/031750A1
The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.  
WO/2009/124723A9
This invention relates to the field of biologically active compounds and specifically to novel aureothin derivatives, pharmaceutical compositions comprising these novel aureothin derivatives, methods for the production of the aureothin d...  
WO/2010/030395A2
The present invention provides a novel class of withanolides that have been isolated from W. somnifera under aeroponic conditions or produced semi-synthetically from withanolide natural products. The invention also provides pharmaceutica...  

Matches 651 - 700 out of 6,862